Morphogenesis, Inc.
Morphogenesis, Inc.
  • Home
    • Scientific Overview
    • Publications
    • Pipeline
    • Clinical Trials
    • Our Philosophy
    • Our Team
    • Our Executive Board
    • Our Intellectual Property
    • Our Bio Facility
    • Newsroom
    • Home
    • Our Science
      • Scientific Overview
      • Publications
    • Clinical Trials
      • Pipeline
      • Clinical Trials
    • About Us
      • Our Philosophy
      • Our Team
      • Our Executive Board
      • Our Intellectual Property
      • Our Bio Facility
      • Newsroom
  • Home

NEWSROOM

Media Coverage

December 17, 2020

November 16, 2020

December 17, 2020

image61

When Entrepreneurship Meets Healthcare: Lessons In Playing The Long Game 

By Shama Hyder - Senior Contributor


Medtech startups must play by a different set of standards than others in the tech world. 


There’s no speeding up product development (if you exclude the extraordinary case of the Covid-19 vaccine, that is). Any tech that’s developed must be rigorously tested, and released only when the product or process has been perfected. 

Continue Reading...

December 17, 2020

November 16, 2020

December 17, 2020

image62

A Brighter Future for Cancer Patients

By Drew Rossow


Under the oversight of the Federal Drug Administration (FDA), Tampa-based immunotherapy company, Morphogenesis, continues to expand its human clinical trials into two more types of cancer. The Company has already completed its first-in-human trial for late-stage melanoma.


Known for developing personalized immunotherapies for cancer treatment through novel cell and gene therapies...

Continue Reading

November 16, 2020

November 16, 2020

November 16, 2020

image63

Finding a better way

By Tyler Francischine - UF Health Writer


As CEO of Morphogenesis Inc., Patricia Lawman, PhD '91, develops novel cell and gene therapies to fight cancer.
Patricia Lawman, PhD ’91, is on a mission to change the future of cancer care. After losing her parents to lung cancer and lymphoma, respectively, she recognized the detrimental impact of radiation and chemotherapy. She knew there must be a way to treat a patient’s cancer without risk of toxicity and other negative side effects. 

Continue Reading

October 15, 2020

October 15, 2020

November 16, 2020

image64

Setting 2020 ablaze: Meet Tampa Bay's Inno on Fire honorees

By Lauren Coffey - TBBJ & Inno Reporter


50 innovators and companies heating up Tampa Bay's tech and startup scene.


It's fair to say 2020 did not go as expected for most. News of startups shuttering, co-founders leaving and funding drying up began to rack up in March and April. But, so did stories of triumph. 

Continue Reading

October 15, 2020

image65

August 28, 2020

August 28, 2020

August 28, 2020

image66

Bioscience firm makes progress on another kind of vaccine...

Business Observer; by Mark Gordon, Managing Editor


The word vaccine carries heavy weight these days, with its tantalizing possibilities to curb the destruction brought on by a certain C-word. But at Tampa-based bioscience company Morphogenesis, the word vaccine is connected  to a different kind of C-word: cancer.

Continue Reading...

July 27, 2020

August 28, 2020

August 28, 2020

image67

USF Health and Tampa biotech firm form clinical research partnership

By Lauren Coffey  – TBBJ & Inno Reporter, Tampa Bay Business Journal


The University of South Florida Health Taneja College of Pharmacy is partnering with a Tampa-based biotech firm to help build the talent pipeline and expand research.


USF Health has partnered with Morphogenesis, a biotechnology company developing immunotherapies for cancer patients, on a two-year contract that runs the gamut. 

Continue Reading...

MAY 18, 2020

August 28, 2020

February 24, 2020

image68

ImmuneFx Gene Therapy Could be a Game Changer for Cancer Treatment

Grit Daily; by Sarah Marshal


Morphogenesis, a clinical stage company that develops novel cell and gene therapies, based out of Tampa, recently got FDA approval to expand human clinical trials with an innovative cancer therapeutic. Grit Daily interviewed Morphogenesis CEO Dr. Patricia Lawman to get more information about this technology that could potentially be a game-changer in regard to cancer treatment. ImmuneFx is currently being studied in advanced Merkel cell carcinoma (MCC) and cutaneous squamous cell carcinoma (cSCC) patients.

Continue Reading...

February 24, 2020

February 24, 2020

February 24, 2020

image69

Tampa's Morphogenesis gets the go-ahead to expand human cancer clinical trials

By Veronica Brezina-Smith  – Reporter, Tampa Bay Business Journal


A Tampa clinical research company working to find a cure for cancer received a green light to expand a trial program.


The Food and Drug Administration has allowed Morphogenesis Inc. to expand its human clinical trials using its ImmuneFx (IFx) cancer vaccine technology for two more types of cancer. 

Continue Reading...

February 21, 2020

February 24, 2020

February 21, 2020

image70

Tampa could be at the center of finding a cure for cancer

CBS-WTSP-TV Author: Eric Glasser


TAMPA, Fla. — Chances are you or somebody you know has battled cancer. But, did you know a potential treatment for the disease is being developed right here in the Tampa Bay area?

The company behind that promising work, Morphogenesis, announced it’s now expanding human trials of its vaccine called ImmuneFx.

“Yes, it’s very exciting,” said Patricia Lawman, CEO of Morphogenesis.

Continue Reading...

August 6, 2019

February 24, 2020

February 21, 2020

image71

Tampa company testing cancer vaccine

News | FOX 13 Tampa Bay


TAMPA, Fla. (FOX 13) - A Tampa company says it is testing a vaccine for cancer.


The vaccine does not prevent cancer. Instead, it explores a new way to help the body fight cancer cells.


Scientists at Morphogenesis, Inc. call the "therapeutic vaccine" a simple and safe technology that could help people who already have cancer fight it off.

Continue Reading...

August 2, 2019

August 27, 2018

August 2, 2019

image72

Morphogenesis to expand clinical trials, physical footprint

By Veronica Brezina-Smith  – Reporter, Tampa Bay Business Journal


The Tampa-based company that’s developing gene and cell therapies to combat cancer is expanding physically and internally.


Morphogenesis, a clinical stage immunotherapy company located in the University Park Center, has been testing its products on various pet animals with 40 different naturally occurring cancers and recently started testing the vaccine on a small group of humans.

Continue Reading...

May 3, 2019

August 27, 2018

August 2, 2019

image73

Coolest Office Spaces: Morphogenesis creates interactive spaces for big minds

By Pam Huff  – Managing Editor, Tampa Bay Business Journal


Morphogenesis is a clinical stage immunotherapy company headquartered in Tampa. The company’s principal focus is a platform of cancer vaccines that utilize both cell and gene therapies to stimulate the immune system to recognize and combat tumor cells.


Since the company is involved in research, development and manufacturing, a unique, creative environment is critical.

Continue Reading...

August 27, 2018

August 27, 2018

August 27, 2018

image74

Tampa company focused on cancer treatment launches first human clinical study

By Margie Manning  –  Finance Editor, Tampa Bay Business Journal


Morphogenesis Inc. is launching its first human clinical study for treatment for skin cancer.


It’s an important benchmark for the Tampa company, which raised $16 million earlier this year in a Series A investment round led by entrepreneur and philanthropist Dr. Kiran Patel.


The Phase 1 study is “the biggest milestone so far” for Morphogenesis, said CEO Patricia Lawman, who co-founded the company in 1995.

Continue Reading...

May 3, 2018

May 3, 2018

August 27, 2018

image75

New HQ puts Tampa immunotherapy company in Moffitt’s backyard

By Margie Manning  –  Finance Editor, Tampa Bay Business Journal


Moffitt Cancer Center has a new neighbor near its McKinley campus.


Morphogenesis Inc., an immunotherapy company that’s just raised $16 million to back its work developing a treatment for cancer, is settling into its new headquarters at 10500 University Center Drive. The 12,000-square-foot headquarters is less than a mile from Moffitt’s outpatient center, where patients in Morphogenesis’ planned clinical trial would be treated, said Patricia Lawman, CEO.

Continue Reading...

Press Releases

Copyright © 2021 Morphogenesis, Inc. - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept